United Health Products, Inc.
UEEC · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.17 | 0.25 | -0.12 | -0.02 |
| FCF Yield | -0.85% | -0.74% | -0.42% | -1.35% |
| EV / EBITDA | -94.60 | -98.94 | -44.93 | -18.28 |
| Quality | ||||
| ROIC | 12.35% | 15.27% | 89.32% | 60.21% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.61 | 0.59 | 0.18 | 0.22 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 5.16% | 32.59% | -51.00% | 43.26% |
| Safety | ||||
| Net Debt / EBITDA | -6.15 | -5.16 | -0.80 | -1.19 |
| Interest Coverage | 7.60 | -5.73 | -35.09 | -27.35 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -85,038.08 | -77,055.32 | -73,583.15 |